These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
681 related articles for article (PubMed ID: 20152228)
1. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry). Lee SW; Park SW; Yun SC; Kim YH; Park DW; Kim WJ; Lee JY; Lee CW; Hong MK; Kim JJ; Park SJ Am Heart J; 2010 Feb; 159(2):284-291.e1. PubMed ID: 20152228 [TBL] [Abstract][Full Text] [Related]
2. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial. Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials). Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913 [TBL] [Abstract][Full Text] [Related]
4. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial. Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ; J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640 [TBL] [Abstract][Full Text] [Related]
6. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen). Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860 [TBL] [Abstract][Full Text] [Related]
7. Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis. Chen Z; Qian J; Chen Y; Ma J; Ge J J Clin Pharmacol; 2013 May; 53(5):532-9. PubMed ID: 23436428 [TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients). Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656 [TBL] [Abstract][Full Text] [Related]
9. What is the optimal duration of triple anti-platelet therapy in patients with acute myocardial infarction undergoing drug-eluting stent implantation? Park KH; Jeong MH; Lee MG; Ko JS; Sim DS; Yoon NS; Yoon HJ; Hong YJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC J Cardiol; 2011 Jan; 57(1):53-60. PubMed ID: 21146365 [TBL] [Abstract][Full Text] [Related]
10. Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials. Sakurai R; Koo BK; Kaneda H; Bonneau HN; Nagai R Int J Cardiol; 2013 Sep; 167(5):2250-8. PubMed ID: 22727963 [TBL] [Abstract][Full Text] [Related]
11. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study. Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F; Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531 [TBL] [Abstract][Full Text] [Related]
12. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Tada T; Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Byrne RA; Kastrati A; Kadota K; Iwabuchi M; Shizuta S; Tazaki J; Shiomi H; Abe M; Ehara N; Mizoguchi T; Mitsuoka H; Inada T; Araki M; Kaburagi S; Taniguchi R; Eizawa H; Nakano A; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T; Circ Cardiovasc Interv; 2012 Jun; 5(3):381-91. PubMed ID: 22619260 [TBL] [Abstract][Full Text] [Related]
13. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents. Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351 [TBL] [Abstract][Full Text] [Related]
14. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry). Lin GM; Chu KM; Han CL Am Heart J; 2010 Sep; 160(3):e21; author reply e23. PubMed ID: 20826238 [No Abstract] [Full Text] [Related]
15. Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials). Lee SW; Lee JY; Ahn JM; Park DW; Han S; Park YK; Lee WS; Jang JY; Kwon CH; Park GM; Cho YR; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ Am J Cardiol; 2013 Dec; 112(11):1738-44. PubMed ID: 24063835 [TBL] [Abstract][Full Text] [Related]
16. Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study. Fiedler KA; Byrne RA; Schulz S; Sibbing D; Mehilli J; Ibrahim T; Maeng M; Laugwitz KL; Kastrati A; Sarafoff N Am Heart J; 2014 Apr; 167(4):459-465.e1. PubMed ID: 24655693 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961 [TBL] [Abstract][Full Text] [Related]
18. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study. Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555 [TBL] [Abstract][Full Text] [Related]
19. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ; Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation. Gao W; Zhang Q; Ge H; Guo Y; Zhou Z Angiology; 2013 Oct; 64(7):554-8. PubMed ID: 23359782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]